Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells-Reference-Cited by-同舟云学术

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Published:2022-09-16 Issue:5 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yamasaki Miho¹,Oda Keisuke²,Ichinose Takashi¹,Mizuguchi Marie¹,Tominaga Shoko¹,Omoda Kei¹,Mori Nobuhiro²,Maeda Yorinobu³,Nishida Toshihiro⁴,Murakami Teruo²

Affiliation:

1. Department of Pharmacy, Chugoku Rosai Hospital, Kure, Hiroshima 737‑0193, Japan

2. Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima 737‑0112, Japan

3. Laboratory of Drug Information Analytics, Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University, Fukuyama, Hiroshima 729‑0292, Japan

4. Department of Diagnostic Pathology, Chugoku Rosai Hospital, Kure, Hiroshima 737‑0193, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference27 articles.

1. Benefits and Risks of fosaprepitant in patients receiving emetogenic regimens;Pritchett;Clin J Oncol Nurs,2016

2. Highly frequent and enhanced injection site reaction induced by peripheral venous injection of fosaprepitant in anthracycline-treated patients;Sato;J Cancer,2014

3. Differential impact of fosaprepitant on infusion site adverse events between cisplatin- and anthracycline-based chemotherapy regimens;Fujii;Anticancer Res,2015

4. An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy;Hegerova;Support Care Cancer,2015

5. Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: A retrospective study;Boccia;Future Oncol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermittent hypoxia increased the expression of ESM1 and ICAM‐1 in vascular endothelial cells via the downregulation of microRNA‐181a1;Journal of Cellular and Molecular Medicine;2023-11-15